Kenta Biotech AG
  • Home
  • Shop
  • Events
  • Courses
  • Services
  • Pricing
  • Company
    • Blog
    • Success Stories
    • About Us
  • Appointment
  • Contact us
  • 0
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
Kenta Biotech AG
  • 0
    • Home
    • Shop
    • Events
    • Courses
    • Services
    • Pricing
    • Company
      • Blog
      • Success Stories
      • About Us
    • Appointment
    • Contact us
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
  1. Products
  2. Tumor
Public Pricelist
Public Pricelist
Sort By: Featured
Featured Newest Arrivals Name (A-Z) Price - Low to High Price - High to Low

Tumor

[0001-356237] Matrigels matrix phenol red free mouse ehs tumor - 10 mL
Matrigels matrix phenol red free mouse ehs tumor - 10 mL
1,109.90 € 1109.9 EUR
[0001-356234] Matrigel basement EHS tumor - 5 mL
Matrigel basement EHS tumor - 5 mL
730.00 € 730.0 EUR
[0870-ABC-TC047S] MBT-2, Mouse Bladder Tumor line-2 Cell Lines
MBT-2, Mouse Bladder Tumor line-2 Cell Lines
3,408.00 € 3408.0 EUR
[0131-LY2088a] Lymphoma tumor tissue array,unstained, unbaked, fresh cut
Lymphoma tumor tissue array,unstained, unbaked, fresh cut
584.00 € 584.0 EUR
[0131-LY2084] Lymphoma tumor survey tissue array (4 of 5), 104 cases/208 cores unstained, fresh cut, unbaked
Lymphoma tumor survey tissue array (4 of 5), 104 cases/208 cores unstained, fresh cut, unbaked
511.00 € 511.0 EUR
[0399-CSB-E16492h-96T] Human soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK)ELISA Test - 96T
Human soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK)ELISA Test - 96T
1,030.00 € 1030.0 EUR
[0855-ELK8750] Human sST2(Soluble Suppression Of Tumorigenicity 2) ELISA Test
Human sST2(Soluble Suppression Of Tumorigenicity 2) ELISA Test
405.00 € 405.0 EUR
[0399-CSB-E08334h-96T] Human p53/tumor protein,p53/TP53 ELISA Test, 96 tests
Human p53/tumor protein,p53/TP53 ELISA Test, 96 tests
1,168.00 € 1168.0 EUR
[0399-CSB-E08334h-96Т] Human p53/tumor protein,p53/TP53 ELISA Test, 96 tests
Human p53/tumor protein,p53/TP53 ELISA Test, 96 tests
983.00 € 983.0 EUR
[0399-CSB-E04740h-96T] Human Tumor necrosis factor α,TNF-α ELISA Test - 96T
Human Tumor necrosis factor α,TNF-α ELISA Test - 96T
950.00 € 950.0 EUR
[0006-E01T0008-96T] Human Tumor Necrosis Factor Alpha ELISA Test, 96 tests
Human Tumor Necrosis Factor Alpha ELISA Test, 96 tests
775.00 € 775.0 EUR
[0445-6801] Human Tumor Necrosis Factor Alpha Detection ELISA Test, 96 test
Human Tumor Necrosis Factor Alpha Detection ELISA Test, 96 test
594.00 € 594.0 EUR
[0855-ELK1190] Human TNFa(Tumor Necrosis Factor Alpha) ELISA Test
Human TNFa(Tumor Necrosis Factor Alpha) ELISA Test
382.00 € 382.0 EUR
[0710-EH0302-96T] Human TNF-α(Tumor Necrosis Factor Alpha) ELISA Test - 96T
Human TNF-α(Tumor Necrosis Factor Alpha) ELISA Test - 96T
650.00 € 650.0 EUR
[0763-E-EL-H0109-96T] Human TNF-α (Tumor Necrosis Factor Alpha) ELISA Test - 96 wells plate
Human TNF-α (Tumor Necrosis Factor Alpha) ELISA Test - 96 wells plate
509.00 € 509.0 EUR
[0089-CAF115] Human Colorectal Tumor CAFs - 1,000,000 cells
Human Colorectal Tumor CAFs - 1,000,000 cells
2,300.00 € 2300.0 EUR
[0980-GMP-C008-50] E. coli Rec. Human Tumor Necrosis Factor a/TNFa, 50ug.
E. coli Rec. Human Tumor Necrosis Factor a/TNFa, 50ug.
385.70 € 385.7 EUR
[0399-CSB-BP024077HU(M1)-100ug.] E. coli Rec. Human Cellular tumor antigen p53(TP53)(Y220C) 100ug.
E. coli Rec. Human Cellular tumor antigen p53(TP53)(Y220C) 100ug.
945.00 € 945.0 EUR
[0399-CSB-YP024077HU(M1)-100ug.] E. coli Rec. Human Cellular tumor antigen p53(TP53)(Y220C) 100ug.
E. coli Rec. Human Cellular tumor antigen p53(TP53)(Y220C) 100ug.
695.00 € 695.0 EUR
[0399-CSB-BP024077HU-100ug.] E. coli Rec. Human Cellular tumor antigen p53(TP53) ug.
E. coli Rec. Human Cellular tumor antigen p53(TP53) ug.
946.00 € 946.0 EUR
  • 1
  • 2
  • 3
  • 4

Clear Filters



Respiratory syncytial virus (RSV) infections are the most common cause of hospitalization in early childhood, accounting for 57 000 to 120 000 hospitalizations each year in the United States. RSV is causing annual epidemics of bronchiolitis and pneumonia worldwide. In most cases the infection with RSV heals without sequelae, yet RSV infection can cause lung function deterioration and in some circumstances, years of recurrent wheezing or asthma may ensue. Overall RSV accounts for an estimated2% of the hospitalization rate among infants less than 1 year of age. This rate increases 4–5-fold among high-risk patients such as premature infants and those with chronic lung disease or complicated congenital heart disease.


Currently there is only one possibility to prevent infections of at-risk patients with RSV, namely immuno-prophylaxis with palivizumab/Synagis, marketed by MedImmune. However, the response to palivizumab is variable among individuals, and sometimes palivizumab fails to prevent RSV infections effectively.


Due to the lack of better antibodies, lack of effective anti-viral treatment and lack of an effective preventive vaccine for RSV, there is a substantial medical need for more efficacious prophylactic immunizations, e.g. by antibody.


Kenta Biotech had developed a fully human monoclonal antibody (KBRV201) derived from B-cells of a human donor. KBRV201 is of the human IgG1 isotype with specificity and very high affinity for the F-protein of human respiratory syncytial virus (hRSV). KBRV201 has been tested for recognition and neutralization of hRSV strains -A, -B and –Long, and KBRV201 could neutralize in vitro all strains tested with higher efficacy than other anti-F-protein mAb.




KBRV201 successfully recognizes 22 clinical isolates from children infected with RSV, including one isolate with a mutated F-protein. Overall KBRV201 has demonstrated superiority in every experiment performed, and KBRV201 is currently undergoing extensive testing in animal models.

14009 NW Harbor Ln, Portland, OR 97229, USA.


Follow us
Copyright © 2025 Kenta Biotech AG
English (UK) English (US)